Cresco Labs Inc. ( CRLBF) - Stock Earnings
CRLBF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | — USD | 164.9 million USD |
| 2025Q4 | — USD | 161.6 million USD |
| 2026Q1 | -9.8 million USD | 151.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CRLBF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 5.3 million USD | 770.9 million USD |
| 2024 | 6.8 million USD | 724.3 million USD |
| 2025 | -3.5 million USD | 655.8 million USD |
| 2026 Est. | — | — |
CRLBF
Price: $0.67
52 week price:
Earnings Per Share: -0.15 USD
P/E Ratio: -6.20
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 276.3 million